Open Access

Imaging of hibernomas: A retrospective study on twelve cases

  • Zafiria G Papathanassiou1, 2,
  • Marco Alberghini1,
  • Sophie Taieb3,
  • Costantino Errani1,
  • Piero Picci1 and
  • Daniel Vanel1Email author
Clinical Sarcoma Research20111:3

DOI: 10.1186/2045-3329-1-3

Received: 17 January 2011

Accepted: 25 July 2011

Published: 25 July 2011

Abstract

Background

To analyze the imaging features of hibernomas on computed tomography (CT) and magnetic resonance (MRI).

Methods

Twelve hibernomas were retrospectively assessed with CT and MR imaging and compared to the histology of the specimen

Results

Nine females and three males with a mean age of 30 years were included. Ten tumors occurred in the thigh and two affected the subcutis of the periscapular and buttock regions. On eight CT scans, seven (87,5%) lesions were homogeneous and mildly to moderately hyperdense compared to subcutaneous fat while one lesion was heterogeneous with mixed hypo and hyperattenuating areas. On six T1W images, five (83,3%) lesions appeared homogeneous and hypointense relative to subcutaneous fat and one was heterogeneous. Incomplete fat suppression was depicted in all cases. All lesions displayed marked enhancement. Large intratumoral vessels were depicted in three of the 12 (25%) cases. Septations were depicted on four of the eight unenhanced CT and on all six MRI examinations.

Conclusions

Hibernoma usually appears hypodense and hypointense relative to subcutaneous fat on pre-contrast CT and MR T1W with variable enhancement patterns and incomplete fat suppression on STIR or fat-saturated sequences. These characteristics relate directly to the presence of brown fat. However, atypical findings such as heterogeneous patterns of mixed fatty and non fatty components on unenhanced CT and MR T1W can be also encountered. Absence of large intratumoral vessels should not exclude hibernomas from the differential diagnosis of regional lipomatous tumors.

Introduction

Hibernomas are rare benign lipomatous tumors originating from residual brown fat cells. At the beginning of the century, Merkel [1] first described them as"pseudolipomas". Owing to their resemblance to the brown fat of hibernating animals, the term "hibernoma" was coined by Gery in 1914 [2]. They affect chiefly adults in the 3rd of 4th decades of life [3] and they usually grow in the vestiges, where brown fat is found in fetuses and infants, such as the shoulder, neck, axilla, the periscapular and interscapular area, thorax and retroperitoneum [4].

The rareness of this lipomatous tumor and its histologic configuration make it a challenging radiologic diagnosis. To the best of author's knowledge only three series [57] and several case reports [818] have exhibited the imaging characteristics of hibernomas. The present study, being the largest in the imaging of hibernomas, highlights the spectrum of imaging appearances (CT/MRI) of twelve histologically proven cases of hibernomas and stresses the positive impact of imaging in the pre-operative planning when a complex fatty mass is encountered.

Materials and methods

Over a 23-year period (1986-2009) fifteen cases diagnosed as hibernomas were identified in the histopathology database of two tertiary referral bone and soft tissue tumor centers. Imaging studies were available in twelve cases. Information regarding age, sex, clinical examination, lesion size and site was registered. Evaluation of the pre-operative imaging investigations (CT-MRI) was performed. Three patients underwent CT and MRI examinations, while five had only CT scans and four had only MRI. Of the latter four patients, two had also ultrasound (U/S) examinations and one of them underwent position emission tomography (18 F FDG-PET). All CT examinations were performed before and after contrast medium intravenous administration. MRI studies obtained from referring institutions included a variety of T1weighted spin-echo (T1WSE), T2weighted spin-echo (T2WSE),T2 weighted fast spin-echo with fat suppression(T2 FSE Fat Sat), short Tau inversion recovery (STIR) and T1W SE with fat suppression sequences(T1 SE Fat Sat). Post gadolinium images were acquired on six cases; one of which had also a MR Angiography. Imaging findings were evaluated by two radiologists (one experienced on bone and soft tissue tumors radiologist and one musculoskeletal radiologist clinical fellow. Radiological assessment included lesion size, location, and internal morphology along with CT attenuation, MR signal intensity and homogeneity, which were compared to subcutaneous fat and muscle. Additionally, contrast enhancement, U/S echogeneity and standard uptake value (SUV) on18 F FDG-PET were recorded. Histopathological analysis was performed by one experienced bone and soft tissue tumor pathologist. All patients had complete but marginal resections of the lesions.

Results

Table 1 displays the imaging appearances of the presented cases. Of the twelve patients nine were female and three male, from 19 to 46 years old (mean: 30 y). Each patient had one lesion and all of them presented with a slow-growing expansion of the affected soft tissue area. Physical examination revealed palpable lumps of various sizes that were painless and relatively mobile. Laboratory tests were not remarkable. Ten of the twelve lesions were located in the upper thigh (eight in the anterior compartment and two in the posterior compartment) and the other two were located subcutaneously in the lower periscapular and buttock regions. All lesions were well circumscribed and presented with fusiform elongated of ovoid shapes. The smallest lesion measured 5,5 × 4,2 × 1 cm and was located in the left periscapular area and the biggest one measured 24 × 12,7 × 7 cm at the postero-medial aspect of the right thigh. Of the eight lesions examined with CT (Figure 1,2,3) seven were mild to moderate hyperdense compared to subcutaneous fat and hypo to isodense relative to muscle. One lesion was heterogeneous with mixed hypo and hyperattenuating areas. Contrast enhancement was obtained by all (eight) lesions with homogeneous (n = 2) and heterogeneous patterns of enhancement (n = 6). On unenhanced images, internal curvilinear structures, consistent with septations, were identified in four cases and were well delineated on post contrast images. The remaining four lesions, which did not present with septations on pre-contrast exams, clearly demonstrated internal vessels after IV contrast medium administration
Table 1

Summary of CT and MRI characteristics of the lesions

Pt no/sex

/age(y)

Size

(cm)

Location

CT attenuation

(pre- cntr)

T1WSE

T2WSE

Fat suppression

(T2FSE FS-STIR)

Cntr

Enhancement

Lesion

Pattern on MRI

(Internal Curvilinear

structures)

1/f/26

9 × 6,5 × 4,1

Rt Thigh

>subc fat

-

-

-

CT/marked heterogeneous

yes

2/f/27

10 × 2 × 4

Rt Thigh

>subc fat

-

<subc fat

-

CT-MRI/marked homogeneous

no

3/f/29

5,5 × 4,2 × 1

Lt Scapula

>subc fat

-

-

-

CT/heterogeneous

yes

4/m/30

15 × 4 × 8,5

Lt Thigh

>subc fat

<subc fat

-

Minimal

suppression

CT-MRI/marked heterogeneous

yes(+large vessels)

5/f/34

8 × 7 × 3

Lt Thigh

-

<subc fat

-

-

-

yes

6/m/46

24 × 12,7 × 7

Rt Thigh

Heterogeneous

Heterogeneous

Heterogeneous

hyperintense

Partial

suppression

CT-MRI/marked heterogeneous

yes(+large vessels)

7/f/19

8 × 6 × 2

Rt Thigh

>subc fat

-

-

-

CT/homogeneous

yes

8/m/31

11 × 7 × 4,2

Rt Thigh

>subc fat

-

-

-

CT/marked heterogeneous

yes

9/f/17

17 × 9 × 4

Rt Thigh

>subc fat

-

-

-

CT/marked heterogeneous

no

10/f/39

9,4 × 5,9 × 4,9

Rt Thigh

-

<subc fat

<subc fat

Partial

suppression

MRI/marked heterogeneous

yes

11/f/31

6 × 4 × 4,5

Lt Buttock

-

<subc fat

-

Minimal

suppression

MRI/marked heterogeneous

yes (+large vessels)

12/f/23

10 × 6 × 6

Lt Thigh

-

<subc fat

<subc fat

Minimal

suppression

MRI/marked homogeneous

yes

https://static-content.springer.com/image/art%3A10.1186%2F2045-3329-1-3/MediaObjects/13569_2011_Article_2_Fig1_HTML.jpg
Figure 1

Unenhanced CT scan (1): A well-defined mass of attenuation close to muscle is located intermuscularly at the anterior aspect of the right upper thigh (asterisk).

https://static-content.springer.com/image/art%3A10.1186%2F2045-3329-1-3/MediaObjects/13569_2011_Article_2_Fig2_HTML.jpg
Figure 2

Axial contrast-enhanced CT scan: Delineation of vessels (black arrows and arrowheads) is apparent on enhanced images.

https://static-content.springer.com/image/art%3A10.1186%2F2045-3329-1-3/MediaObjects/13569_2011_Article_2_Fig3_HTML.jpg
Figure 3

Sagital contrast-enhanced CT scan. Vessels are well visible (white arrows and arrowheads)

On T1-weighted images, five lesions appeared slightly hypointense relative to subcutaneous fat and hyperintense compared to muscle while the largest tumor showed heterogeneous-mixed intensity with components of increased and decreased intensity (Figure 4,5,6,7,8,9). Three out of four lesions examined with T2-weighted sequences, presented with slightly hypointense masses compared to subcutaneous fat and one was heterogeneously hyperintense. On STIR and T2 fat sat sequences, only minimal to partial signal loss was depicted (Figure 7) in all cases. One patient, who had additionally a MR angiography exhibited rich vascularity of the lesion as well as the origin of the blood supply from the epigastric and deep femoral vessels (Figure 10,11,12). Post gadolinium images (T1WSE/T1 SE Fat Sat) revealed marked heterogeneous enhancement in four lesions and marked homogeneous in two lesions. Internal curvilinear and branching structures of low signal intensity on T1WSE and T2WSE were shown in all six cases (Figure 13,14,15,16,17). Gadolinium uptake was not visible in all curvilinear strands (Figure 2B, 4A-D). On the other hand, post gadolinium visualization of vessels was noticed in all six cases. Intratumoral vessels of larger caliber were detected in three of the 12 (25%) cases. (Figure 2E-F,4E,5D-E). The sonographic appearance of the two lesions was that of a heterogeneous hyperechoic mass containing prominent vasculature (Figure 18,19). On18 F FDG-PET scan, the subcutaneous lesion at the left buttock presented with an increased SUV value (Figure 20,21,22,23,24,25,26). All patients experienced an uneventful post-surgical recovery. No case relapsed.
https://static-content.springer.com/image/art%3A10.1186%2F2045-3329-1-3/MediaObjects/13569_2011_Article_2_Fig4_HTML.jpg
Figure 4

Axial T1WSE.

https://static-content.springer.com/image/art%3A10.1186%2F2045-3329-1-3/MediaObjects/13569_2011_Article_2_Fig5_HTML.jpg
Figure 5

Axial T2WSE The mass contains ill-defined areas of lower intensity relative to subcutaneous fat on T2WSE.Internal septations are evident (curved double arrow).

https://static-content.springer.com/image/art%3A10.1186%2F2045-3329-1-3/MediaObjects/13569_2011_Article_2_Fig6_HTML.jpg
Figure 6

Post gadolinium image. The mass of heterogeneous mixed intensities exhibits diffuse enhancement. Unenhanced curvilinear septations are well visible (curved double arrow).

https://static-content.springer.com/image/art%3A10.1186%2F2045-3329-1-3/MediaObjects/13569_2011_Article_2_Fig7_HTML.jpg
Figure 7

Partial loss of fat signal intensity is depicted on STIR images.

https://static-content.springer.com/image/art%3A10.1186%2F2045-3329-1-3/MediaObjects/13569_2011_Article_2_Fig8_HTML.jpg
Figure 8

Sagital reformatted image clearly exhibits large intratumoral vessels (black arrows).

https://static-content.springer.com/image/art%3A10.1186%2F2045-3329-1-3/MediaObjects/13569_2011_Article_2_Fig9_HTML.jpg
Figure 9

Axial reformatted image.

https://static-content.springer.com/image/art%3A10.1186%2F2045-3329-1-3/MediaObjects/13569_2011_Article_2_Fig10_HTML.jpg
Figure 10

Axial PD WSE exhibits an intermuscular soft tissue mass that is hypointense relative to subcutaneous fat (arrow).

https://static-content.springer.com/image/art%3A10.1186%2F2045-3329-1-3/MediaObjects/13569_2011_Article_2_Fig11_HTML.jpg
Figure 11

Homogeneous enhancement is observed (arrow).

https://static-content.springer.com/image/art%3A10.1186%2F2045-3329-1-3/MediaObjects/13569_2011_Article_2_Fig12_HTML.jpg
Figure 12

On MRA, blood supply is originated from epigastric and deep femoral vessels (arrows).

https://static-content.springer.com/image/art%3A10.1186%2F2045-3329-1-3/MediaObjects/13569_2011_Article_2_Fig13_HTML.jpg
Figure 13

Axial T1WSE before injection.

https://static-content.springer.com/image/art%3A10.1186%2F2045-3329-1-3/MediaObjects/13569_2011_Article_2_Fig14_HTML.jpg
Figure 14

Axial T1WSE after injection enhanced (white arrows) and unenhanced (black arrows) thin curvilinear structures corresponding to fibrovascular and fibrous tissue, respectively.

https://static-content.springer.com/image/art%3A10.1186%2F2045-3329-1-3/MediaObjects/13569_2011_Article_2_Fig15_HTML.jpg
Figure 15

Axial T1WSE before injection at another level.

https://static-content.springer.com/image/art%3A10.1186%2F2045-3329-1-3/MediaObjects/13569_2011_Article_2_Fig16_HTML.jpg
Figure 16

The same level after injection.

https://static-content.springer.com/image/art%3A10.1186%2F2045-3329-1-3/MediaObjects/13569_2011_Article_2_Fig17_HTML.jpg
Figure 17

On T2 GRE sequence, internal thin vessels are also seen (thin black arrows).

https://static-content.springer.com/image/art%3A10.1186%2F2045-3329-1-3/MediaObjects/13569_2011_Article_2_Fig18_HTML.jpg
Figure 18

Ultrasonography exhibits a mild heterogeneous hyperechoic mass.

https://static-content.springer.com/image/art%3A10.1186%2F2045-3329-1-3/MediaObjects/13569_2011_Article_2_Fig19_HTML.jpg
Figure 19

It contains prominent vessels with Doppler.

https://static-content.springer.com/image/art%3A10.1186%2F2045-3329-1-3/MediaObjects/13569_2011_Article_2_Fig20_HTML.jpg
Figure 20

T1WSE: subcutaneous mass of the lateral aspect of the left buttock that is clearly hypointense to subcutaneous fat.

https://static-content.springer.com/image/art%3A10.1186%2F2045-3329-1-3/MediaObjects/13569_2011_Article_2_Fig21_HTML.jpg
Figure 21

T1WSE FAT SAT: the lesion is poorly pre saturated.

https://static-content.springer.com/image/art%3A10.1186%2F2045-3329-1-3/MediaObjects/13569_2011_Article_2_Fig22_HTML.jpg
Figure 22

T1WSE FAT SAT with gadolinium: the lesion contains vessels of various sizes (black arrows).

https://static-content.springer.com/image/art%3A10.1186%2F2045-3329-1-3/MediaObjects/13569_2011_Article_2_Fig23_HTML.jpg
Figure 23

On 18 F FDG-PET scan, the lesion has shown increased FDG accumulation.

https://static-content.springer.com/image/art%3A10.1186%2F2045-3329-1-3/MediaObjects/13569_2011_Article_2_Fig24_HTML.jpg
Figure 24

Gross surgical specimen reveals an encapsulated, lobular mass with yellow-tan to dark brown cut surfaces.

https://static-content.springer.com/image/art%3A10.1186%2F2045-3329-1-3/MediaObjects/13569_2011_Article_2_Fig25_HTML.jpg
Figure 25

Hematoxylin-Eosin stain: Multiple multivacuolated cells are identified with some scattered white adipocytes.

https://static-content.springer.com/image/art%3A10.1186%2F2045-3329-1-3/MediaObjects/13569_2011_Article_2_Fig26_HTML.jpg
Figure 26

Immunohistochemistry: S-100 positivity is evident.

Discussion

Hibernomas are rare slow-growing benign tumors that consist of brown fat. In 1670, Welch [19] was the first to describe this specialized form of adipose tissue in hibernating animals. None the less, brown fat is also found in more than fifty nonhibernating species, such as human fetuses and newborns [20]. It is believed to represent a kind of fetal fat whose function is to promote nonshivering thermogenesis and gradually is replaced by white adipose tissue with advancing postnatal age to finally comprise less than 0, 1% of the total body weight by the age of 70 years [4, 17, and 21]. However, it may persist in various portions throughout adulthood [9]. Hibernoma is the only tumor known to occur within brown fat and can grow at any location where brown fat remains [6, 16]. Most commonly hibernomas form in the vestiges where brown fat has remained from fetal life such as the periscapular and interscapular region, the neck, axilla, mediastinum, upper thorax and retroperitoneum [4, 22, 23]. Other uncommon locations include the abdomen, thigh, buttock, popliteal fossa and intracranial sites [4]. Based on the largest and most valid demographic study (Soft Tissue AFIP Registry), by Furlong MA et al [3], hibernomas affect mainly adults in the 3rd and 4th decades of life (61% of cases) with a mean age of 38 years. Unlike the previous published data, the AFIP series [3] demonstrates a slight male predominance (58% of cases) with the thigh being the most common location (30% of cases). Our study results are consistent with the aforementioned findings regarding age (range: 19-46 y, mean: 30 y) and location (83,3% of cases located in the thigh) but on the other hand a clear female predilection (75% of cases) is shown in this series.

Generally hibernomas exhibit a rather quiet clinical behavior and present as slow growing soft tissue masses that are usually painless and relative mobile. Owing to the tumor's hypervascularity, localized warmth can be depicted over the lesion at palpation [4, 6, 7, 14, 15]. The lesions can become symptomatic when compression of nearby structures occurs [6, 15]. No evidence of a malignant form of hibernoma has been reported in the English literature, except for the case published as an abstract by Teplitz et al. [24] that involved a sarcoma with hibernoma-like features. Incomplete excision results in local recurrence of the tumor; therefore marginal but complete resection is considered as the treatment of choice for these lesions [14, 24]. Even though core needle biopsy is not recommended in cases of suspected hibernoma due to the tumor's hypervascularity [9, 14, 25] all of the presented cases were preoperatively biopsied without any complications. From a macroscopic aspect, hibernomas are well-defined, encapsulated soft, lobulated masses and the color ranges from tan to red brown [15] (Figure 4G.). They usually measure from 5 to 10 cm in diameter, but they may reach up to 20 cm [4, 15]. Microscopically, the tumor is characterized by multivacuolated cells with eccentric nuclei and granular eosinophilic cytoplasm, univacuolated cells with peripheral nuclei, and smaller round cells with granular cytoplasm. The hypervascularity and the presence of cells with eosinophilic granular cytoplasm full of mitochondria give hibernomas their brown color [4, 6, 18]. From an histological point of view this entity must be distinguished from granular cell tumor, that is a benign peripheral nerve derived tumor composed of granular cells rich in mitochondria. In this regard immunohistochemistry does not help, because both tumors intensely stain for S-100 protein. The main histological difference is that hibernoma shows much more pleomorphism and focally show typical mature adipocytes, in between the granular cells. The diagnosis of lipomatoustumors is often very difficult. Molecular pathology can better classify these lesions and made past classifications out of date. But cytogenetics studies do not help in the diagnosis of hibernoma [26].

According to the 2002 WHO classification there are six histologic subtypes of hibernomas [27]. These are only of diagnostic relevance and not of prognostic value. Histopathologic evaluation of hibernomas, as previously described, is well-established and pathognomonic. On the contrary, CT and MRI features are not specific and vary with the nature and amount of lipid component [4, 12, 18, 19, 22, 23]. Non contrast CT usually demonstrates a well-demarcated soft tissue mass of predominantly low attenuation which is close but not identical to subcutaneous fat. On the other hand, more heterogeneous patterns can be encountered as well, as in this series. Internal linear, curvilinear or branching septations-like densities may be contained [7, 9, 10]. On post contrast scans, enhancement of the septa as well as more diffuse uptake, usually occurs [7, 9, and 23]. Diffuse enhancement was depicted in all the present cases whereas internal enhancing linear or curvilinear densities were shown in four out of eight cases, indicating thus internal vasculature. Even though vessels were shown in the remaining four cases on post contrast images; the absence of septations in these lesions prior to contrast infusion was attributed to the fact that these lesions had attenuations closer to muscle than fat. On MR images, as in previously published data [616, 18], five out of six lesions presented, on T1WSE sequences, slightly to moderately decreased signal intensity relatively to subcutaneous fat and only one showed a heterogeneous-mixed signal intensity including areas of increased and decreased intensity but on the whole slightly lower than subcutaneous fat, probably due to a greater "hibernoma" component. Three lesions on T2WSE images demonstrated slightly lower intensities than subcutaneous fat; although most authors report signal intensities closer to fat [5, 7, 9, 1114]. The heterogeneous lesion on T1WSE remained heterogeneously hyperintense on T2WSE images as well. Finally, like in most cases [57, 1317], STIR and T2 fat sat sequences failed to achieve full suppression of the examined hibernomas and displayed the most heterogeneous patterns. Gadolinium enhancement, either heterogeneous or homogeneous, is usually present in hibernomas [5, 7, 1118]; even though Cook M et al [8] and Lee J [6] et al did not report any significant gadolinium uptake in their cases. Although, internal curvilinear structures of low signal intensity were observed on T1WSE and T2WSE sequences in all lesions, they didn't exhibit the same degree of enhancement most likely corresponding to hypocellular fibrous and fibrovascular tissue interspersed with the fatty and non fatty portions of the tumor [6, 14]. Little is known regarding the imaging of hibernomas on18 F FDG-PET scans. The reported high FDG accumulation in these fat-containing tumors may be attributed to the metabolically active cellular elements rather than reflect their malignant or not potential [28, 29].

Various differential considerations, based on imaging, can be suggested when a complex fatty mass is encountered, including benign entities like lipoma, angiolipoma and hemangioma as well as malignant tumors like liposarcoma. Lipomas present as homogeneous fatty masses with few scattered internal septa and no signs of enhancement [6]. Angiolipomas and hemangiomas can be distinguished in terms of different morphology of internal vasculature [13, 16, 17]. Several studies [4, 1618] stress the importance of large branching intratumoral vessels with early contrast enhancement and AV shunting in the differential diagnosis of hibernomas. However these features are not always present, although fine enhancing strands may be seen [6]. In the present series, internal vessels were apparent in six MRI exams; while in total three lesions contained vessels of larger caliber as well. So, vascularity either in the form of thin enhancing septa or in the form of vessels is primarily anticipated in hibernomas. On the other hand, absence of large intratumoral vessels should not exclude hibernomas from the differential diagnosis. Well-differentiated liposarcomas are characterized by the presence of irregularly thick (>2 mm) and/or nodular septa, foci of high T2 and prominent areas of enhancement [6, 15]. Moreover, the fatty component of a well-differentiated liposarcoma appears isointense to subcutaneous fat, on T1WSE; distinguishing them from hibernomas [6]. Other lesions like myxoid liposarcoma and clear cell sarcoma could be similar to brown fat tumors but the former displays intense heterogeneity on T2 sequences and the latter primarily involves a tendon, ligament or aponeurosis [13].

This study has limitations, such as limited number of cases, and examinations performed with different techniques. None the less, this study comprises the largest number of cases of this rare tumor published thus far and elaborates effectively on its various imaging appearances. Conclusively, even if CT and MRI features are not specific, hibernoma should be strongly suggested if a soft tissue mass, exhibits higher attenuation than subcutaneous fat on CT, slightly lower signal intensity relative to subcutaneous fat on T1WSE, marked enhancement and partial fat suppression on STIR and fat-saturated sequences. These differences compared to subcutaneous fat, especially on MRI, reflect the different nature of lipid component of hibernomas and comprise the cornerstone in differentiating them from malignant lipomatous tumors. However, as in this study, other atypical findings such as more heterogeneous patterns of mixed fatty and non fatty components on unenhanced CT and MR T1W may be encountered. Furthermore internal septations, regardless of enhancement, and thin vessels contribute in establishing the diagnosis. The role of large intratumoral vessels remains questionable in characterizing hibernomas. While complete surgical resection is curative for hibernomas, knowledge of its MRI and CT features can help narrow the field of differential diagnosis and modify adequately the pre-operative planning of complex lipomatous tumors.

Declarations

Authors’ Affiliations

(1)
Research, The Rizzoli Institute
(2)
Pathology C, The Rizzoli Institute
(3)
Centre Oscar Lambret

References

  1. Merkel H: On a pseudolipoma of the breast. Beitr Pathol Anat. 1906, 39: 152-57.Google Scholar
  2. Gery L: Discussions. Bull Mem Soc Anat (Paris). 1914, 89: 111-Google Scholar
  3. Furlong MA, Fanburg-Smith JC, Miettinen M: The morphologic spectrum of hibernoma: a clinicopathologic study of 170 cases. Am J Surg Pathol. 2001, 25 (6): 809-14. 10.1097/00000478-200106000-00014View ArticlePubMedGoogle Scholar
  4. Murphey MD, Carroll JF, Flemming DJ, Pope TL, Gannon FH, Kransdorf MJ: From the archives of the AFIP: benign musculoskeletal lipomatous lesions. Radiographics. 2004, 24 (5): 1433-66. 10.1148/rg.245045120View ArticlePubMedGoogle Scholar
  5. Ritchie DA, Aniq H, Davies AM, Mangham DC, Helliwell TR: Hibernoma--correlation of histopathology and magnetic-resonance-imaging features in 10 cases. Skeletal Radiol. 2006, 35 (8): 579-89. 10.1007/s00256-006-0114-4View ArticlePubMedGoogle Scholar
  6. Lee JC, Gupta A, Saifuddin A, Flanagan A, Skinner JA, Briggs TW, Cannon SR: Hibernoma: MRI features in eight consecutive cases. Clin Radiol. 2006, 61 (12): 1029-34. 10.1016/j.crad.2006.05.018View ArticlePubMedGoogle Scholar
  7. Dursun M, Agayev A, Bakir B, Ozger H, Eralp L, Sirvanci M, Guven K, Tunaci M: CT and MR characteristics of hibernoma: six cases. Clin Imaging. 2008, 32 (1): 42-7. 10.1016/j.clinimag.2007.07.001View ArticlePubMedGoogle Scholar
  8. Cook MA, Stern M, de Silva RD: MRI of a hibernoma. J Comput Assist Tomogr. 1996, 20 (2): 333-5. 10.1097/00004728-199603000-00032View ArticlePubMedGoogle Scholar
  9. Alvine G, Rosenthal H, Murphey M, Huntrakoon M: Hibernoma. Skeletal Radiol. 1996, 25 (5): 493-6. 10.1007/s002560050122View ArticlePubMedGoogle Scholar
  10. Lewandowski PJ, Weiner SD: Hibernoma of the medial thigh. Case report and literature review. Clin Orthop Relat Res. 1996, 198-201. 330,
  11. Peer S, Kühberger R, Dessl A, Judmaier W: MR imaging findings in hibernoma. Skeletal Radiol. 1997, 26 (8): 507- 10.1007/s002560050276View ArticlePubMedGoogle Scholar
  12. Mugel T, Ghossain MA, Guinet C, Buy J, Bethoux J, Texier P, Vadrot D: MR and CT findings in a case of hibernoma of the thigh extending into the pelvis. Eur Radiol. 1998, 8 (3): 476-8. 10.1007/s003300050419View ArticlePubMedGoogle Scholar
  13. Anderson SE, Schwab C, Stauffer E, Banic A, Steinbach LS: Hibernoma: imaging characteristics of a rare benign soft tissue tumor. Skeletal Radiol. 2001, 30 (10): 590-5. 10.1007/s002560100405View ArticlePubMedGoogle Scholar
  14. Kallas KM, Vaughan L, Haghighi P, Resnick D: Hibernoma of the left axilla; a case report and review of MR imaging. Skeletal Radiol. 2003, 32 (5): 290-4. 10.1007/s00256-002-0533-9View ArticlePubMedGoogle Scholar
  15. da Motta AC, Tunkel DE, Westra WH, Yousem DM: Imaging findings of a hibernoma of the neck. AJNR Am J Neuroradiol. 2006, 27 (8): 1658-9.PubMedGoogle Scholar
  16. Colville J, Feigin K, Antonescu CR, Panicek DM: Hibernoma: Report emphasizing large intratumoral vessels and high T1 signal. Skeletal Radiol. 2006, 35 (7): 547-50. 10.1007/s00256-005-0048-2View ArticlePubMedGoogle Scholar
  17. Tomihama RT, Lindskog DM, Ahrens W, Haims AH: Hibernoma: a case report demonstrating usefulness of MR angiography in characterizing the tumor. Skeletal Radiol. 2007, 36 (6): 541-5. 10.1007/s00256-006-0241-yView ArticlePubMedGoogle Scholar
  18. Kumazoe H, Nagamatsu Y, Nishi T, Kimura YN, Nakazono T, Kudo S: Dumbbell-shaped thoracic hibernoma: computed tomography and magnetic resonance imaging findings. Jpn J Radiol. 2009, 27 (1): 37-40. 10.1007/s11604-008-0289-9View ArticlePubMedGoogle Scholar
  19. Kransdorf M, Murphey M: Lipomatous tumors. Imaging of soft tissue tumors. 1997, 57-101. Philadelphia, Pa: Saunders,Google Scholar
  20. Rasmussen A: The so-called hibernating gland. J Morphol. 1923, 147-50.Google Scholar
  21. Heaton JM: The distribution of brown adipose tissue in the human. Anat. 1972, 112 (Pt 1): 35-9.Google Scholar
  22. Drevelegas A, Pilavaki M, Chourmouzi D: Lipomatous tumors of soft tissue: MR appearance with histological correlation. Eur J Radiol. 2004, 50 (3): 257-67. 10.1016/j.ejrad.2004.01.022View ArticlePubMedGoogle Scholar
  23. Bancroft LW, Kransdorf MJ, Peterson JJ, O'Connor MI: Benign fatty tumors:classification clinical course imaging appearance and treatment. Skeletal Radiol. 2006, 35 (10): 719-33. 10.1007/s00256-006-0189-yView ArticlePubMedGoogle Scholar
  24. Lele SM, Chundru S, Chaljub G, Adegboyega P, Haque AK: Hibernoma: a report of 2 unusual cases with a review of the literature. Arch Pathol Lab Med. 2002, 126 (8): 975-8.PubMedGoogle Scholar
  25. Lung RJ, Lapidus S, Miller SH, Graham WP: Hibernoma: report of two cases. J Surg Oncol. 1977, 9 (6): 563-6. 10.1002/jso.2930090606View ArticlePubMedGoogle Scholar
  26. Weiss SW, Goldblum JR: Benign lipomatous tumors. Soft tissue tumors. Edited by: Weiss SW, Goldblum JR. 2008, 466-St. Louis: Mosby, 5,Google Scholar
  27. Miettinen MM, Fanburg-Smith JC, Mandhl N: Hibernoma. World Health Organization classification of tumours. Pathology and genetics of tumours of soft tissue and bone. Edited by: Fletcher CDM, Unni KK, Mertens F. 2002, 33-35. Lyon: IARC Press,Google Scholar
  28. Burdick MJ, Jolles PR, Grimes MM, Henry DA: Mediastinal hibernoma simulates a malignant lesion on dual time point FDG imaging. Lung Cancer. 2008, 59 (3): 391-4. 10.1016/j.lungcan.2007.08.020View ArticlePubMedGoogle Scholar
  29. Subramaniam RM, Clayton AC, Karantanis D, Collins DA: Hibernoma: 18F FDG PET/CT imaging. J Thorac Oncol. 2007, 2 (6): 569-70. 10.1097/JTO.0b013e31805fe2a5View ArticlePubMedGoogle Scholar

Copyright

© Papathanassiou et al; licensee BioMed Central Ltd. 2011

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.